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Sphingomonas paucimobilis is an aerobic Gram-negative bacillus found in soil and
water. Knowledge regarding the role of this infectious agent is limited because it
is rarely isolated from human material. Furthermore, it is an unusual pathogen
in cases of peritoneal dialysis (PD)-associated peritonitis. The clinical courses
and outcomes of peritonitis caused by S. paucimobilis are variable. Whereas some
patients were cured with appropriate antibiotic therapy, others required catheter
removal. Cases of PD-associated peritonitis caused by S. paucimobilis have been
reported worldwide, and there was a case report of coinfection with S. paucimobilis
and Chryseobacterium indologenes in Korea. However, there has been no case caused
by S. paucimobilis as a single pathogen. We report a case of PD-associated peritonitis
due to S. paucimobilis in which the patient recovered after catheter removal.
& 2013. The Korean Society of Nephrology. Published by Elsevier. This is an open
access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Continuous ambulatory peritoneal dialysis (CAPD) is an
important treatment option for patients who are at the end
stage of renal disease. Although the rate of peritonitis has
declined in recent years because of improvements in the
CAPD technique, peritonitis remains the leading cause for
discontinuation of CAPD [1].
Sphingomonas paucimobilis is frequently isolated from
environmental sources such as soil and water, and it is found
on hospital equipment such as ventilators, nebulizers, and
humidiﬁers [2,3]. Although S. paucimobilis plays an extremely
limited role as an infectious agent [4], it is responsible for two
types of human infections: community-acquired infection and
nosocomial infection [5]. Cases of peritonitis by S. paucimobilis
have been reported rarely. The clinical outcomes were diverserean Society of Nephrology. P
ses/by-nc-nd/4.0/).
al Medicine, Presbyterian
ee).in previously reported peritoneal dialysis (PD)-associated
peritonitis cases [2,5–7]. Furthermore, deﬁnitive guidelines
do not exist for treating S. paucimobilis.
Cases of PD-associated peritonitis caused by S. paucimobilis
have been reported worldwide, and one case caused by coin-
fection with S. paucimobilis and Chryseobacterium indologenes
was reported in Korea [8]. However, this is the ﬁrst case report
of peritonitis due to S. paucimobilis as a single pathogen in
Korea. We describe a case of PD-associated peritonitis due to
S. paucimobilis that was resolved after catheter removal.Case report
A 63-year-old man who had been treated with CAPD for
6 years was admitted to our hospital because of a turbid
peritoneal efﬂuent accompanied by constant abdominal pain
that began 2 days prior to his admission. The underlying cause
of the patient’s end-stage renal disease was diabetes mellitus
and hypertension, and his dialysis treatment consisted of fourublished by Elsevier. This is an open access article under the CC BY-NC-
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farming and lived in the countryside. He had been treated for
peritonitis with Pseudomonas aeruginosa and Staphylococcus
epidermidis 7 months previously.
On admission, his blood pressure was 165/80 mmHg, heart
rate was 84 beats/min, respiratory rate was 19/min, and body
temperature was 36.8 1C. His abdomen was diffusely tender
with normal bowel sounds, and infection was not found around
the catheter exit site. The laboratory ﬁndings showed PD
peritonitis: the white blood cell (WBC) count of the peritoneal
efﬂuent was 2,040/mm3 with a neutrophil predominance (85%).
His hemoglobin was 11.3 g/dL, WBC count was 7.6109/L,
and C-reactive protein was 5.9 mg/dL (normal: o0.8 mg/dL).
Bacteria were not observed on Gram stain examination. After
peritoneal ﬂuid was sent for bacterial culture, a single 1-g dose
of cefazolin and a single 1-g dose of ceftazidime were given
intraperitoneally per day. Two peritoneal ﬂuid samples were
inoculated into a BACTEC plus Aerobic/F culture bottle (Becton
Dickinson Diagnostic Instrument System, Drogheda, Ireland)
and incubated in a BACT/ALERT 3D Blood Culture System
(Biomerieux, Marcy letoile, France). Culture of the peritoneal
dialysate revealed S. paucimobilis, which was susceptible to
ceftazidime, cefotaxime, imipenem, meropenem, gentamicin,
ciproﬂoxacin, and minocycline, and resistant to piperacillin,
aztreonam, and colistin.
The peritoneal WBC decreased to 30/mm3 and the patient’s
clinical condition improved on the ﬁfth day after starting
intraperitoneal ceftazidime. The patient was discharged on
Day 7 with 7-day intraperitoneal antibiotics. The next day after
14 days of intraperitoneal ceftazidime, abdominal pain devel-
oped again, and the efﬂuent became turbid. The peritoneal
efﬂuent contained 2,880 WBC/mm3, of which 75% were neu-
trophils. Abdominal computed tomography and ultrasonogra-
phy were normal. We started a 1-g dose of intraperitoneal
imipenem twice daily instead of cefazolin and ceftazidime.
The culture of the peritoneal dialysate at second admission
showed S. paucimobilis that was resistant to ceftazidime,
ampicillin/sulbactam, piperacillin, cefotaxime, cefepime, aztreo-
nam, and amikacin, and susceptible to imipenem, meropenem,
ciproﬂoxacin, minocycline, and trimethoprim-sulfamethoxazole.Figure 1. WBC counts froHowever, the patient’s abdominal pain persisted and the WBC
count of the peritoneal efﬂuents became elevated to 4,300/mm3
(Figure 1). Therefore, we removed the Tenckhoff catheter 3 days
later despite continued imipenem therapy, and PDwas switched
to hemodialysis. The culture of the catheter tip was negative.
Imipenem was continued for another week and the patient’s
clinical condition improved. The patient has been maintained on
hemodialysis after catheter removal.Discussion
PD-associated peritonitis caused by S. paucimobilis is rare,
and this bacillus has not been reported as the single causative
pathogen of PD-associated peritonitis in Korea. We report a
case of peritonitis due to S. paucimobilis that required catheter
removal.
S. paucimobilis is a yellow-pigmented, gram-negative bacillus
that has a single polar ﬂagellum with slow mobility. These bacteria
are aerobic, nonfermentative, oxidase positive, and catalase-
positive [9]. Although human infections caused by S. paucimobilis
are generally rare [4], these infections appear to have increased
in humans in recent years [10]. Such a ﬁnding was probably
considered to be associated with hospital-acquired infection due
to indwelling intravascular devices [3,10]. Peritonitis caused by
S. paucimobilis has been reported in patients undergoing peritoneal
dialysis. In Korea, only one case of peritonitis caused by
S. paucimobilis and C. indologenes has been reported [8]. However,
this is the ﬁrst case report of PD-associated peritonitis due to S.
paucimobilis as a single pathogen in Korea.
Since the ﬁrst two cases of PD-associated peritonitis by
S. paucimobilis were described by Glupczynski et al [2],
several other cases have been reported, with diverse clin-
ical courses and outcomes [2,5–7]. Although Hsueh et al [3]
suggested that imipenem alone or an aminoglycoside plus a
third-generation cephalosporin could effectively treat
infections caused by S. paucimobilis, no deﬁnitive guideline
exists for the treatment of this organism. In previous
reports, half of the reported cases were treated successfully
with antibiotics alone, but the other half underwentm peritoneal efﬂuent.
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tinued to grow in peritoneal efﬂuent cultures upon the
patient’s second admission, and the peritoneal WBC count
was increased despite the use of antibiotics such as imipe-
nem for 3 days. Therefore, we removed the Tenckhoff
catheter and PD was switched to hemodialysis.
In the case discussed here, at ﬁrst admission, the dialysate
was clear and abdominal pain disappeared following intraper-
itoneal administration of ceftazidime, which was effective
against S. paucimobilis. However, peritonitis by the same organ-
ism recurred on the 15th day during antibiotic treatment. In this
circumstance, adding aminoglycoside or changing antibiotics to
imipenem was helpful for treatment of peritonitis caused by
S. paucimobilis [3], so we decided to use imipenem because the
patient had a urine output of more than 1,000 mL per day.
According to International Society for Peritoneal Dialysis guide-
lines, antibiotics dose should be empirically increased by 25% in
patients with residual renal function [11]. However, residual
renal function was not considered in deciding the antibiotic
dose. Thus, inadequate dosage of antibiotics might be one of the
possible causes of treatment failures in this case.
In summary, we report a case of PD-associated peritonitis
caused by S. paucimobilis that was treated by catheter
removal. Therefore, catheter removal could be considered in
cases of PD-associated peritonitis caused by S. paucimobilis.
Adequate antibiotics dosage is essential to treat this rare
peritonitis, especially in patients with residual renal function.Conﬂict of interest
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